Principles: mechanisms and modeling of synergism in cellular responses.

Cells can be considered as integrators of simultaneous stimuli, in which cross-talk between transduction pathways can eventually produce responses that are significantly different from simply additive responses. Synergism represents an efficient means of increasing the amplitude of cellular responses induced by low levels of stimulation. Recently, several kinetic and physicochemical models have been developed to describe and predict synergistic responses. In this article, the mechanisms that control the magnitude and timing of cellular synergism are discussed. We suggest that the analysis of theoretical models could enable a general prediction of synergism despite the presence of signal-specific synergistic responses. In addition, application of the proposed concepts should aid understanding of the wide occurrence of synergism induced by interacting transduction pathways in multi-drug clinical treatment.

[1]  T. Buchman.  The community of the self , 2002, Nature.

[2]  M. Yamaguchi,et al.  H(2)O(2) and ethanol act synergistically to gate ryanodine receptor/calcium-release channel. , 2000, American journal of physiology. Cell physiology.

[3]  Malcolm Rowland,et al.  Kinetics of drug-drug interactions , 1973, Journal of Pharmacokinetics and Biopharmaceutics.

[4]  A. Salvador,et al.  Synergism analysis of biochemical systems. II. Tensor formulation and treatment of stoichiometric constraints. , 2000, Mathematical biosciences.

[5]  A. Salvador,et al.  Synergism analysis of biochemical systems. I. Conceptual framework. , 2000, Mathematical biosciences.

[6]  S. Torres,et al.  Prediction of synergism on frequency of responses in the attojoule range , 2004 .

[7]  Meindert Danhof,et al.  Pharmacodynamic Analysis of the Anticonvulsant Effects of Tiagabine and Lamotrigine in Combination in the Rat , 2004, Epilepsia.

[8]  I. Paul,et al.  Agmatine reduces only peripheral-related behavioral signs, not the central signs, of morphine withdrawal in nNOS deficient transgenic mice , 2004, Neuroscience Letters.

[9]  J. Zasadzinski,et al.  Synergistic interactions of lipids and myelin basic protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  F. Aricioglu,et al.  Effect of agmatine on the development of morphine dependence in rats: potential role of cAMP system. , 2004, European journal of pharmacology.

[11]  Hong-Bin Fang,et al.  Experimental design and sample size determination for testing synergism in drug combination studies based on uniform measures , 2003, Statistics in medicine.

[12]  Noriko Yasuhara,et al.  Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy , 1997, Nature.

[13]  Hannu Raunio,et al.  Prediction of drug metabolism and interactions on the basis of in vitro investigations. , 2005, Basic & clinical pharmacology & toxicology.

[14]  B. Kholodenko,et al.  Quantification of information transfer via cellular signal transduction pathways , 1997, FEBS letters.

[15]  M. L. Mandich,et al.  Time-resolved optical diagnostics of radio frequency plasmas , 1985 .

[16]  S. Strogatz.  Exploring complex networks , 2001, Nature.

[17]  Y. Sugiyama,et al.  Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport. , 1998, Annual review of pharmacology and toxicology.

[18]  D. A. Bergstrom,et al.  Multisecond oscillations in firing rate in the globus pallidus: synergistic modulation by D1 and D2 dopamine receptors. , 1999, The Journal of pharmacology and experimental therapeutics.

[19]  J. Rabalais,et al.  Synergetic effects in ion beam energy and substrate temperature during hyperthermal particle film deposition , 1998 .

[20]  M. Danhof,et al.  Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo. , 2005, Pharmacology & therapeutics.

[21]  R. Tallarida,et al.  Theory and statistics of detecting synergism between two active drugs: cocaine and buprenorphine , 1997, Psychopharmacology.

[22]  D. Graves,et al.  Chemical and physical sputtering of fluorinated silicon , 1995 .

[23]  M. Ehrenberg,et al.  Stochastic focusing: fluctuation-enhanced sensitivity of intracellular regulation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Guido Jenster.  A visualisation concept of dynamic signalling networks , 2004, Molecular and Cellular Endocrinology.

[25]  R. Levy,et al.  Inhibition-based metabolic drug-drug interactions: predictions from in vitro data. , 2002, Journal of pharmaceutical sciences.

[26]  E. Szathmáry,et al.  Do deleterious mutations act synergistically? Metabolic control theory provides a partial answer. , 1993, Genetics.

[27]  M. Villalón,et al.  Functional cross talk after activation of P2 and P1 receptors in oviductal ciliated cells. , 2000, American journal of physiology. Cell physiology.

[28]  C. Rao,et al.  Control, exploitation and tolerance of intracellular noise , 2002, Nature.

[29]  Wei Gu,et al.  Synergistic activation of transcription by CBP and p53 , 1997, Nature.

[30]  A. L. Goldin,et al.  Potentiation of rat brain sodium channel currents by PKA in Xenopus oocytes involves the I-II linker. , 2000, American journal of physiology. Cell physiology.

[31]  R. Tallarida,et al.  Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved Isoboles , 2004, Journal of Pharmacology and Experimental Therapeutics.

[32]  R. Tallarida.  The interaction index: a measure of drug synergism , 2002, Pain.